The Rundown AI -每日精选 07月31日 15:33
The AI aiming to 'solve all diseases'
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

谷歌DeepMind的衍生公司Isomorphic Labs正利用其AlphaFold技术,将AI驱动的药物研发推向人体试验新阶段。该公司已获得6亿美元融资,并与诺华、礼来等巨头达成合作,目标是构建一个能按需生成治疗方案的“药物设计引擎”,最终实现“攻克所有疾病”的愿景。AI在预测蛋白质结构和分子相互作用方面的能力,有望颠覆传统的药物研发模式,开启一个更快、更精准的时代。同时,文章也关注了AI在代码辅助、管理决策以及职业发展等多个领域的应用和影响。

🚀 Isomorphic Labs利用AlphaFold 3技术,将AI设计的抗癌药物推向人体临床试验,旨在通过AI按需生成治疗方案,最终实现“攻克所有疾病”的宏伟目标。该公司已获得6亿美元融资,并与多家大型制药公司建立合作关系。

⚖️ 华为Pangu Pro模型被指控抄袭阿里巴巴Qwen 2.5模型,引发了关于AI研发伦理和知识产权的争议。尽管华为否认抄袭,但此事件凸显了在激烈的市场竞争中,AI领域的道德规范和透明度面临的挑战。

💻 通过Context7 MCP,AI编码助手能够连接到实时、版本特定的代码文档,从而避免过时的代码示例和API“幻觉”。在编码提示后添加“use context7”指令,可以确保获得准确、最新的代码建议。

💼 一项调查显示,60%的管理者正在使用AI工具来做出关键的业务和人事决策,包括薪资、晋升和解雇。ChatGPT是其中最常用的工具,但许多管理者在缺乏AI培训和指导的情况下,就允许AI做出最终决定,这引发了对AI在管理层应用的担忧。

💡 AI在多个领域展现出巨大潜力,从药物研发到代码辅助,再到管理决策。然而,伴随而来的是对数据隐私、模型安全、以及AI对就业市场影响的讨论,预示着AI的广泛应用需要审慎的态度和周全的考量。

Read Online | Sign Up | Advertise

Good morning, {{ first_name | AI enthusiasts }}. "Solving all diseases" sounds like Silicon Valley hype — until you realize the company making the claim has $600M in funding and a Nobel Prize-winning technology.

Google DeepMind spinoff Isomorphic Labs is set to take its AlphaFold-powered treatments from computer simulations into human trials, chasing a vision where AI can generate cures on demand.


In today’s AI rundown:

    Isomorphic Labs’ AI-created drugs near human trials

    Chinese giant under fire over model copying

    Get code documentation in AI coding assistants

    AI takes the wheel for managerial decisions

    4 new AI tools & 4 job opportunities

LATEST DEVELOPMENTS

ISOMORPHIC LABS

💊 Isomorphic Labs’ AI-created drugs near human trials

Image source: Midjourney / The Rundown

The Rundown: Alphabet's AI-powered drug discovery company, Isomorphic Labs, is preparing to start its first human clinical trials for its AI-designed cancer drugs, with an ultimate goal of “solving all diseases.”

The details:

    The DeepMind spinoff has spent four years developing drugs using AlphaFold 3, an AI system for predicting protein structures and molecular interactions.

    The team secured $600M in fresh funding in April, fueling both in-house drug candidates and major multi-billion dollar partnerships with Novartis and Eli Lilly.

    The company envisions creating a "drug design engine" that could eventually generate treatments on demand to “solve all diseases.”

    Human dosing is expected to begin soon, with oncology as the first clinical focus, and plans to license successful candidates after early trials.

Why it matters: If Isomorphic’s approach delivers, pharma’s previous trial-and-error model could give way to a faster, more precise era where AI can design new treatments that get tested via simulations before entering the lab. “Solving all diseases” is a utopian vision — but at least one Nobel Prize winner agrees that it is in sight.

TOGETHER WITH VANTA

🛡️ Live Event: Security, AI, and Trust

The Rundown: Vanta’s Trust Maturity Report proves mature security is a catalyst, not a cost center. Join Vanta and security researcher Matt Johansen on July 23 to dig into the report findings and explore what trust maturity looks like at every stage of growth.

In this live session, you’ll discover:

    What’s changed (and what hasn’t) about how teams build trust through security

    Deep insights from Vanta’s data research team

    Tips for how high-maturity organizations are scaling security through AI

    Tactical advice for getting buy-in and making measurable progress

Register here.

HUAWEI & ALIBABA

🔥 Chinese giant under fire over model copying

Image source: Reve / The Rundown

The Rundown: Chinese giant Huawei’s research arm is pushing back on accusations that its new Pangu Pro model was copied from Alibaba's Qwen 2.5, coming after whistleblowers posted technical analysis showing similarities between the two systems.

The details:

    A GitHub group called HonestAGI initially published (now deleted) findings accusing Pangu of having an “extraordinary correlation” with Qwen 2.5-14B.

    Huawei's Noah Ark Lab denied the claims, saying Pangu was independently developed and the first system built on the company’s Ascend chips.

    A whistleblower claiming to work at Huawei then posted on GitHub, alleging Pangu cloned third-party models while under pressure to catch up to rival labs.

Why it matters: The Chinese AI wave has felt more united than the deeper rivalries of closed Western leaders, but high-stakes domestic competition looks to be pushing teams towards ethical shortcuts. Will Chinese giants remain committed to the open-source push if their work is getting re-skinned by one of their biggest competitors?

AI TRAINING

🔧 Get code documentation in AI coding assistants

The Rundown: In this tutorial, you will learn how to use Context7 MCP to connect your AI coding assistant to real-time, version-specific documentation, eliminating outdated code examples and hallucinated APIs.

Step-by-step:

    Open Cursor Settings and select “Tools and Integrations”

    Click “Add new global MCP server” and paste the Context7 configuration URL found here

    Test with a project prompt: “Create a React to-do list application. use context7”

    Compare the updated, accurate code vs. generic AI responses

Pro tip: End every coding prompt with “use context7” to get real-time, version-specific documentation instead of outdated training data.

PRESENTED BY RETELLIO

🤝 Meet your AI Product Manager

The Rundown Retellio’s AI Product Manager finds the most common bugs and feature requests in your customer conversations, writes PRDs, and sends them to AI coding agents like Cursor — so you get pull requests that automatically fix real issues and get work done.

Retellio’s AI Product Manager can:

    Listen to your customers across your calls, tickets, etc. to capture feedback

    Surface the most important problems and draft specs on demand

    Collaborate with Cursor to auto-deploy pull requests for lightning-fast bug fixes

Get your invite today.

AI RESEARCH

💼 AI takes the wheel for managerial decisions

Image source: Resume Builder

The Rundown: A new survey from Resume Builder found that 60% of managers are using AI tools to make critical business and personnel decisions, allowing the tech to determine raises, promotions, and firings with minimal oversight or training.

The details:

    Resume Builder surveyed 1,342 managers and found that 78% use AI to determine raises, 77% for promotions, and 64% for terminations.

    ChatGPT dominated as the primary tool for 53% of AI-using managers, followed by Microsoft Copilot at 29% and Google Gemini at 16%.

    One in five managers also frequently allow AI to make final decisions without human review, despite most never receiving formal AI training or guidelines.

    Nearly half of the managers were asked to evaluate whether AI could replace their team members, with 43% following through on replacements.

Why it matters: AI is already entrenched in the managerial department — but just as entry-level jobs have been the first to be automated, lower-level employees are again those being impacted by supervisors offloading decisions to ChatGPT. As models scale in intelligence, will owners automating managers out of the equation be next?

QUICK HITS

🛠️ Trending AI Tools

    📄 Genspark AI Docs - Create a variety of document types with text prompts

    📈 Context - AI office suite for working smarter, faster, and more efficiently

    🗣️ Voicelab - High-performance API to run top open-source voice models

    🔎 StepFun Diligence Check - AI-powered search with agent-verified citations

💼 AI Job Opportunities

📰 Everything else in AI today

Elon Musk revealed that xAI’s highly-anticipated Grok 4 model will be released on Wednesday, July 9.

Anthropic published a Transparency Framework, pushing to require AI labs to release plans for assessing model risks, system cards, whistleblower protections, and more.

Tencent’s Hunyuan released Hunyuan 3D-PolyGen, a new 3D AI model designed for professional art-grade outputs for game development and artist modeling.

The Mayo Clinic introduced Vision Transformer, an AI system for detecting surgical-site infections quickly and accurately via photos during outpatient monitoring.

AI semiconductor startup Groq announced its first European data center in Helsinki, Finland, aiming to position its LPU chips as a cheaper alternative to Nvidia.

Several publishers filed an EU antitrust complaint against Google for its AI Overviews, saying the AI summaries are causing “significant harm” to traffic and revenue.

COMMUNITY

🎥 Join our next live workshop

Join our next workshop this Wednesday, July 9th at 3 PM EST with Tomek Sułkowski, Founding Engineer and DevRel Lead at Bolt. By the end of the session, you’ll confidently build and deploy scalable apps using Bolt.

RSVP here. Not a member? Join The Rundown University on a 14-day free trial.

See you soon,

Rowan, Joey, Zach, Alvaro, and Jason—The Rundown’s editorial team

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

Isomorphic Labs AlphaFold AI药物研发 AI伦理 AI在管理中的应用
相关文章